Clinical Utility of the Neutrophil Elastase Inhibitor Sivelestat for the Treatment of Acute Respiratory Distress Syndrome
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s65066
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2014
Authors
Publisher
Informa UK Limited